Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
150
NCT04470947
Comprehensive Genomic Profiling and Next Generation Functional Drug Screening for Patients With Aggressive Haematological Malignancies
Phase: N/A
Role: Collaborator
Start: Jun 10, 2020
Completion: Mar 31, 2026